Pain Therapeutics Income Statement
View: Annual | Quarterly
| Dec 07 | Dec 06 | Dec 05 | |
|---|---|---|---|
| Revenue | 66.0 | 53.9 | 5.1 |
| Cost of Goods Sold | -- | -- | -- |
| Gross Profit | -- | -- | -- |
| Gross Profit Margin | 0.0% | 0.0% | 0.0% |
| SG&A Expense | 55.5 | 80.3 | 37.4 |
| Depreciation & Amortization | 0.4 | (25.9) | 0.4 |
| Operating Income | 10.2 | (0.6) | (32.7) |
| Operating Margin | 15.4% | -- | -- |
| Nonoperating Income | 10.1 | 9.7 | 2.0 |
| Nonoperating Expenses | -- | -- | -- |
| Income Before Taxes | 20.3 | 9.1 | (30.7) |
| Income Taxes | -- | 2.9 | -- |
| Net Income After Taxes | 20.3 | 6.2 | (30.7) |
| Continuing Operations | 20.3 | 6.2 | (30.7) |
| Discontinued Operations | -- | -- | -- |
| Total Operations | 20.3 | 6.2 | (30.7) |
| Total Net Income | 20.3 | 6.2 | (30.7) |
| Net Profit Margin | 30.8% | 11.5% | -- |
| Diluted EPS from Total Net Income ($) | 0.44 | 0.14 | (0.70) |
| Dividends per Share | -- | -- | -- |





